Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for evaluation of Hermansky-Pudlak Syndrome (HPS) associated pulmonary fibrosis. Reports progressive exertional dyspnea, non-productive cough, and reduced exercise tolerance. History significant for oculocutaneous albinism, bleeding diathesis (platelet storage pool deficiency), and known genetic confirmation of HPS. Review of systems positive for restrictive lung disease symptoms; negative for acute infectious triggers or hemoptysis.
Clinical Examination Findings
General: Patient appears chronically ill, resting tachypnea noted. Skin: Hypopigmentation consistent with oculocutaneous albinism. HEENT: Nystagmus and iris transillumination present. Respiratory: Bilateral fine end-inspiratory crackles (Velcro-like) at lung bases. Cardiac: Regular rate and rhythm, prominent P2 suggesting pulmonary hypertension. Extremities: No digital clubbing or peripheral edema noted.
Treatment Protocol
Management plan: 1. Pulmonary function testing (PFTs) with DLCO monitoring. 2. High-resolution computed tomography (HRCT) to assess fibrosis progression. 3. Consider antifibrotic therapy (e.g., Pirfenidone or Nintedanib) per clinical guidelines. 4. Supplemental oxygen as needed for hypoxemia. 5. Evaluation for lung transplantation in advanced disease. 6. Multidisciplinary coordination with hematology and ophthalmology.